Abstract
Herein, novel manganese sulfide nanoparticles (MnS NPs) decorated reduced graphene oxide (rGOS) nanocomposite have been designed through a facile ultrasound-assisted method and followed by a sonication process. After then, as-synthesized α-MnS@rGOS was characterized by HRTEM, FESEM, XPS, XRD and EIS. Furthermore, the α-MnS@rGOS nanocomposite modified SPCE (screen-printed carbon electrode) shows excellent electrochemical sensing performance towards Parkinson’s disease biomarker of dopamine (DA). Moreover, the fabricated sensor showed a wide linear range for dopamine between 0.02 and 438.6 µM and nanomolar detection limit (3.5 nM). In addition, the α-MnS@rGOS modified SPCE showed selectivity towards the detection of dopamine in presence of a 10-fold higher concentration of other important biomolecules. The nanocomposite film modified SPCE sensor was good stable and reproducible towards the detection of Parkinson's disease biomarker. Furthermore, the as-synthesized α-MnS@rGOS nanocomposite modified SPCE has been applied to the determination of dopamine in human serum, rat serum and pharmaceutical samples with acceptable recoveries.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
